Tomorrow's Health, Today's Research

Dr. Leigh Anne Swayne

Assistant Professor, Division of Medical Sciences
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Phone: (250) 853-3723
Department page

Research area: Bioelectric control of neural stem and progenitor cells; neural stem cells in brain repair; pannexins and voltage-gated sodium and calcium channel superfamily members: structure, function and regulation by protein-protein interactions.

_________________________________________________________________________________

Research Profile

Pannexin expert adds to UVic’s strengths in brain repair research

Although the last decade has seen some spectacular advances in neuroscience, getting neurons to regenerate on demand is tantalizingly out of reach for a group of neuroscience researchers at UVic who would like to lessen the dignity-robbing effects of Alzheimer’s, Parkinson’s and stroke. The most recent addition to this research group, Dr. Leigh Anne Swayne of the Island Medical Division, is following up on her success in an exciting new area of brain research: the role of pannexin proteins.

To back up a little and explain the extent of the challenge to repair brains, Swayne explains that neural stem cells are rare (they are only found in two parts of the brain) and very tightly controlled in ways that we don’t yet understand.

“We don’t even know how to get the stem cells to the site of damage,” she says.Ideally, we’d fully understand the mechanism that control neural growth in order to manipulate them to help a patient recover damage to the brain. It was this promise of many new and important proteins yet to be discovered in the brain that led Swayne to look at a recently discovered family of proteins called pannexins.

Pannexins are interesting for several reasons. They are closely related to connexins (proteins that form gap junctions between cells, an important way that cells communicate with each other in vertebrates). Pannexins were discovered when researchers starting combing the wealth of genome data that started to emerge in the last decade, looking for proteins in higher animals that corresponded to connexins and innexins (the invertebrate version of connexins). The result was a family of distinct proteins that are extraordinarily ancient, and found in most living multicellular organisms. Unlike connexins that usually connect cell-to-cell, pannexins often just make hemichannels, connecting a cell to the extracellular space. But most intriguing, they are found in the brain, where there were immediate signs that they were involved with neural development.

“I like to think of them (hemichannels) as tasters of the environment -- testing ions, metabolites, signaling molecules,” says Swayne. This might explain how pannexins can have an effect on cell signaling and cell development.

Thus pannexins became a hot area of research and Swayne was at the forefront of adding to this excitement during her time as a post doctoral fellow at the University of Ottawa, when she discovered that the gap junction Panx2, acts like a gate keeper to neurogenesis, holding neural stem cells in their stem cell state, until Panx2 is told to stand down.

Swayne was drawn to UVic in 2010, in part because of the synergy that is starting to happen in neuroscience on the West Coast. Swayne feels UVic is the perfect place to combine her molecular background (she started in protein and lipid biochemistry), with whole organism studies and behavioural studies already going on at UVic and UBC.

“I remember the first time I held a brain in a neuro-anatomy class during my PhD, and I thought, ‘This was in someone’s head, and they thought with it.’ It was very weird,” she says. Ever since then Swayne’s wanted to gradually broaden her research scope so she could relate cellular mechanisms to what is going on in a thinking, feeling, learning individual, which is something she plans to do here at UVic.

But for now, as she builds her new neuroscience lab, her research focus is to understand the molecular mechanism of neuron regeneration, starting with building on her success with pannexins.

Looking forward, she is full of questions, such as: when and how are pannexins normally expressed? What signals are carried by pannexin channels, and how do those signals change a neural population?

For part of her research, she is collaborating with UVic neurobiologist Dr. Craig Brown (also in UVic’s Division of Medical Sciences), who has been working with mice to understand neural regeneration following brain damage from a stroke. Apparently after a stroke, brains will undergo a massive proliferation of new neural cells, but the majority of these new cells then die. Swayne explains that a natural question is to wonder, what if you could prevent some of those cells from dying? Would it improve recovery?

Swayne is working with Brown’s mice model to test whether pannexins are involved in the proliferation and death of cells following stroke, and if these signals can be manipulated – without causing a loss of cell growth control. Not surprisingly, one of Swayne’s colleagues, Dr. Christian Naus at UBC, has found a connection between Panx1 and Panx2 and brain cancer, which is both encouraging – it strengthens the theory that pannexins controls cell growth ‑ and discouraging. Clearly there is much work to be done before a brain repair therapy is developed.

The leg bone is connected to the arm bone

How does the nervous system coordinate the arms and legs during walking? Professor Dr. E. Paul Zehr has expanded the focus of neuroscientists studying motor control, leading to new treatments for stroke victims. More

Poxvirus expert creates bioinformatics tools

Dr. Chris Upton bridges gap between genetics and computers with the Viral Bioinformatics Resource Center. More

An eye for detail

Dr. Jim Tanaka, a cognitive neuroscientist, is examining whether autistic children can be taught to overcome "face blindness" by engaging a part of their brains, which they use to expertly recognize other objects. More

A new way to look for cancer biomarkers

Dr. Terry Pearson is banking on mass spectrometry to be the next big thing for antibody-based diagnosis. More

Elegant strategy works against broad range of cancers

Dr. Brad Nelson thinks the time is right for T cell therapy. More

Why nicotine is addictive, yet good for the brain

Neuroscientist Dr. Raad Nashmi found a new pathway for nicotine addiction, which also helps explain nicotine’s benefits for those prone to Parkinson’s. More

Tracking genetic disorders

Whether he is finding a genetic cure or tracking a rare mutation, Dr. Patrick Macleod is a vital link between patients and molecular researchers at the CBR. More

 

Bringing the power of genomics to aquaculture

Dr. Ben Koop co-founded the consortium for Genomic Research on All Salmon Project (cGRASP), an international team devoted to understanding salmon from its DNA out: its evolutionary history, its ecology, its health. More

Speed up and lighten up

Neuroscientist Dr. Sandra Hundza explores ways to teach people to walk again after a neurotrauma like a stroke or spinal cord injury, based on understanding the neural patterns that control rhythmic movement

Listening to cells talk

The field of signal transduction is fulfilling its early promise of cancer cures. Professor Dr. Perry Howard is looking for signals to kill cancer cells. More

Learning, Dopamine and ADHD

Subheadline for CBR front page flash: Cognitive neuroscientist Dr. Clay Holroyd is rephrasing the symptom of “inability to focus” to “an inability to get the appropriate dopamine reward for focus.” More

The promise of synthetic molecules for controlling proteins

If you can’t find the right chemical tool to suit your medical research, you could ask chemist Dr. Fraser Hof to build one. Histone experts eye up Hof’s latest: a synthetic molecule that binds histones, disrupting a gene regulation pathway. More

A better way to test for pollutants

Forty years after Rachel Carson wrote Silent Spring, Dr. Caren Helbing’s work warns us that we still don’t really know how to test for chemical contaminants in the environment. More

CBR founder tackles risks and ethics

Dr. Barry Glickman helps Health Canada and the Canadian Space Agency sort through the hype to find the real potential — and threats — of nanotechnology. More

Order in the chaos

Dr. Roderick Edwards finds patterns invisible to the naked eye, as he seeks for order in systems as complex as neuronal nets. More

Salmon genome gives clues to evolution

Dr. Johan de Boer describes how a salmon ancestor diverged so quickly into dozens of species thanks to transposons. More
 

Exercise reverses fetal alcohol syndrome (FAS)

Dr. Brian Christie was one of the first neuroscientists to discover that exercise promotes the generation of new brain cells. In his latest research, he found that exercise can even reverse FAS-related brain damage. More

The heartbreak of tracking rare mutations

Dr. Francis Choy's study of inherited diseases has immediate impact on patients. More

Watching eyes grow

Dr. Robert Chow is finding genes that control eye development. More

Syphilis expertise leads to whale research

When Dr. Caroline Cameron is not studying syphilis, she’s catching snot from whales: the strange path from syphilis to marine biology. More

Sea urchin sequence accelerates discoveries

Dr. Robert Burke has seen developmental biology grow up and zoom in. When he helped finish the sea urchin sequence in 2006, the field took another quantum leap forward. More

Deciphering the Histone Code

Dr. Juan Ausio helped figure out the structure and nature of chromatin, which led to the idea of a histone code. More